Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.

Autor: Acharya NR; From the F.I. Proctor Foundation, University of California (N.R.A., J.A.G., T.D., A.C., T.C.P., J.G.S.), San Francisco, California, USA; Department of Ophthalmology, University of California (N.R.A., J.A.G., T.D., T.C.P., J.G.S.), San Francisco, California, USA; Department of Epidemiology and Biostatistics, University of California (N.R.A.), San Francisco, California, USA. Electronic address: Nisha.Acharya@ucsf.edu., Rathinam SR; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology (S.R.R., R.T., R.V.), Madurai, India., Thundikandy R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology (S.R.R., R.T., R.V.), Madurai, India., Kanakath A; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology (A.K.), Coimbatore, India., Murugan SB; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology (S.B.), Pondicherry, India., Vedhanayaki R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology (S.R.R., R.T., R.V.), Madurai, India., Gonzales JA; From the F.I. Proctor Foundation, University of California (N.R.A., J.A.G., T.D., A.C., T.C.P., J.G.S.), San Francisco, California, USA; Department of Ophthalmology, University of California (N.R.A., J.A.G., T.D., T.C.P., J.G.S.), San Francisco, California, USA., Lim LL; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital (L.L.L.), East Melbourne, Australia., Suhler EB; Casey Eye Institute, Oregon Health and Science University (E.B.S.), Portland, Oregon, USA., Al-Dhibi HA; Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital (H.A.A.D.), Riyadh, Kingdom of Saudi Arabia., Doan T; From the F.I. Proctor Foundation, University of California (N.R.A., J.A.G., T.D., A.C., T.C.P., J.G.S.), San Francisco, California, USA; Department of Ophthalmology, University of California (N.R.A., J.A.G., T.D., T.C.P., J.G.S.), San Francisco, California, USA., Arellanes-Garcia L; Asociación Para Evitar la Ceguera (L.A.G.), Mexico City, Mexico., Coyne A; From the F.I. Proctor Foundation, University of California (N.R.A., J.A.G., T.D., A.C., T.C.P., J.G.S.), San Francisco, California, USA., Porco TC; From the F.I. Proctor Foundation, University of California (N.R.A., J.A.G., T.D., A.C., T.C.P., J.G.S.), San Francisco, California, USA; Department of Ophthalmology, University of California (N.R.A., J.A.G., T.D., T.C.P., J.G.S.), San Francisco, California, USA., Shantha JG; From the F.I. Proctor Foundation, University of California (N.R.A., J.A.G., T.D., A.C., T.C.P., J.G.S.), San Francisco, California, USA; Department of Ophthalmology, University of California (N.R.A., J.A.G., T.D., T.C.P., J.G.S.), San Francisco, California, USA.

Publikováno v: American journal of ophthalmology [Am J Ophthalmol] 2024 Nov; Vol. 267, pp. 100-111. Date of Electronic Publication: 2024 Jun 22.

Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.

Autor: Sundararajan M; Department of Ophthalmology, University of Washington, Seattle, Washington, USA.; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA., Rathinam SR; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Thundikandy R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India., Kanakath A; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India., Balamurugan S; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Pondicherry, India., Vedhanayaki R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Miller DC; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA., Lim LL; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia., Suhler EB; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA., Al-Dhibi HA; Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia., Arellanes-Garcia L; Inflammatory Eye Disease Clinic, Asociación Para Evita la Ceguera en México, México City, México., Reddy AK; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, Anschutz Medical School, University of Colorado, Denver, Colorado, USA., Feng S; Department of Ophthalmology, University of Washington, Seattle, Washington, USA., Doan T; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA., Porco TC; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA., Shantha JG; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA., Acharya NR; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA., Gonzales JA; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA.

Publikováno v: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Aug 27, pp. 1-8. Date of Electronic Publication: 2024 Aug 27.

National Eye Institute's (NEI) coordination efforts and current opportunities for sustainability, adaptation, and climate resilience in global eye health - ARVO 2023 session commentary.

Autor: McCance E; Department of Ophthalmology, Royal Glamorgan Hospital, Llantrisant, UK. elliemccance@gmail.com., Taylor HR; Melbourne School of Population and Global Health, Melbourne, VIC, Australia., Acharya NR; Departments of Ophthalmology and Epidemiology, University of California, San Francisco, USA., Thiel CL; Department of Population Health & Ophthalmology, New York University, New York, NY, USA., Resnikoff S; School of Optometry and Vision Sciences, University of New South Wales, Sydney, NSW, Australia., Bourne R; Cambridge Eye Research Centre, Addenbrookes Hospital, Cambridge, UK.

Publikováno v: Eye (London, England) [Eye (Lond)] 2024 Aug; Vol. 38 (11), pp. 1984-1985. Date of Electronic Publication: 2023 Nov 30.

Real-World Vaccine Research and Clinical Practice.

Autor: Kumar A; F. I. Proctor Foundation, University of California, San Francisco, San Francisco., Acharya NR; F. I. Proctor Foundation, University of California, San Francisco, San Francisco.; Department of Ophthalmology, University of California, San Francisco, San Francisco.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco.

Publikováno v: JAMA ophthalmology [JAMA Ophthalmol] 2024 Jun 01; Vol. 142 (6), pp. 528-529.

Acute neuroretinitis as a delayed manifestation of tubulointerstitial nephritis and uveitis syndrome.

Autor: Vazquez SE; School of Medicine, University of California San Francisco, San Francisco, CA, USA., Niemeyer K; Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA., Mentreddy A; Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA., Gonzales J; Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA., Rasool N; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA., Acharya NR; Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA., Doan T; Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA., Shantha JG; Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.

Publikováno v: American journal of ophthalmology case reports [Am J Ophthalmol Case Rep] 2024 Apr 16; Vol. 34, pp. 102050. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).